ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0654

The Effects of Dietary Macronutrients on Serum Urate: A Secondary Analysis of the OmniHeart Trial

Matthew Belanger1, Christina Wee1, Kenneth Mukamal1, Edgar Miller2, Frank Sacks3, Lawrence Appel2, Robert Shmerling4, Hyon Choi5 and Stephen Juraschek1, 1Beth Israel Deaconess Medical Center/Harvard Medical School, Division of General Medicine, Boston, MA, 2Johns Hopkins University, School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, MD, 3Harvard T. H. Chan School of Public Health, Department of Nutrition, Boston, MA, 4Beth Israel Deaconess Medical Center/Harvard Medical School, Division of Rheumatology, Mashpee, MA, 5Massachusetts General Hospital, Department of Medicine, Division of Rheumatology, Lexington, MA

Meeting: ACR Convergence 2020

Keywords: Cardiovascular, diet, gout, nutrition, Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Metabolic & Crystal Arthropathies Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Diet is a significant determinant of hyperuricemia and risk for gout. Dietary recommendations to prevent gout emphasize reducing purine intake; however, low-purine diets are often ineffective in preventing gout and have unknown effects on cardiovascular disease risk factors, such as hypertension and hyperlipidemia, which often accompany gout. Meanwhile, studies suggest that the DASH diet reduces serum urate while also lowering blood pressure and lipids. Whether DASH-pattern diets that emphasize different macronutrient proportions might enhance serum urate reduction is not known.

Methods: We conducted a secondary analysis of the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OmniHeart) feeding study, a 3-arm, crossover design, randomized trial of 191 adults with prehypertension or stage I hypertension (defined at the time of the trial as systolic blood pressure 120-159 mm Hg or diastolic blood pressure 80-99 mm Hg) who were not on antihypertensive medications. Participants were randomized to one of three DASH-pattern diets that emphasized either carbohydrates (CARB), protein (PROT), or unsaturated fat (UNSAT). Calories were adjusted as needed to maintain body weight throughout the study. We compared the effects of these diets on serum urate at weeks 4 and 6 of each feeding period.

Results: A total of 163 participants were included in the final analysis (mean age 53.5 yrs, 45% women, 55% black). The mean BMI was 30.2 kg/m2 and 56.7% had hypertension. The PROT diet reduced serum urate from baseline at the end of the 6-week feeding period (-0.16 mg/dL; 95% CI: -0.28, -0.05; P = 0.006) (Table 1). In contrast, neither the CARB diet (-0.03 mg/dL; 95% CI: -0.15, 0.09; P = 0.63) or the UNSAT diet (-0.01 mg/dL; 95% CI: -0.11, 0.09; P = 0.81) reduced serum urate. Compared with the CARB and UNSAT diets, the PROT diet lowered serum urate by 0.12 mg/dL (95% CI: -0.20, -0.04; P = 0.005) and 0.12 mg/dL (95% CI: -0.20, -0.05; P = 0.001), respectively (Table 2). When stratified by baseline serum urate ≥ 6 mg/dL (n = 29), all diets significantly reduced serum urate from baseline (-0.39 to -0.52 mg/dL) and there was no significant difference between diets.

Conclusion: A DASH-pattern diet emphasizing plant-based protein lowered serum urate compared with those emphasizing carbohydrates or unsaturated fat. These findings suggest that a DASH-pattern diet emphasizing plant-based protein may enhance serum urate reduction. Overall, a DASH-pattern diet emphasizing plant-based protein has the potential to lower serum urate while also improving hypertension and hyperlipidemia. A definitive trial to test the ability of a DASH-pattern diet emphasizing plant-based protein to lower the incidence of gout is warranted.


Disclosure: M. Belanger, None; C. Wee, None; K. Mukamal, United States Highbush Blueberry Council, 2; E. Miller, None; F. Sacks, None; L. Appel, None; R. Shmerling, None; H. Choi, AstraZeneca, 2, Takeda, 5, Selecta, 5, GlaxoSmithKline, 5, Horizon, 5; S. Juraschek, None.

To cite this abstract in AMA style:

Belanger M, Wee C, Mukamal K, Miller E, Sacks F, Appel L, Shmerling R, Choi H, Juraschek S. The Effects of Dietary Macronutrients on Serum Urate: A Secondary Analysis of the OmniHeart Trial [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-effects-of-dietary-macronutrients-on-serum-urate-a-secondary-analysis-of-the-omniheart-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-dietary-macronutrients-on-serum-urate-a-secondary-analysis-of-the-omniheart-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology